BLK vs CRL · P/E 27, rev $24.22B vs rev $2.00B
BlackRock Inc (BLK) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
BLK currently screens at market cap $172.19B and trailing P/E 26.6. CRL currently screens at market cap $7.78B.
Not investment advice. Open the BLK and CRL stock pages for the full models.
Not investment advice.